Skip to content

biological monitoring

BIOLOGICAL2 trials

Sponsors

University of Roma La Sapienza, Centre Hospitalier Universitaire Dijon

Conditions

Proven Pathogenic or Probably Pathogenic TBR1 VariantSpecific Antibody ResponseVaccination Adverse EventsVaccination Failure

Related Papers